Krystal Biotech, Inc. (KRYS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 80.38M | 77.51M | 39.66M | 52.73M | 30.97M | 52.84M | 58.86M | -4.17M | 15.89M | -7.23M | -21.23M | -34.19M |
| Operating CF Margin % | 69.08% | 72.37% | 40.55% | 54.9% | 35.12% | 57.98% | 70.2% | -5.93% | 35.11% | -17.16% | -248.08% | - |
| Operating CF Growth % | 159.56% | 46.68% | -32.62% | 1365.09% | 94.92% | 830.68% | 377.29% | 87.81% | 160.74% | 67.61% | -7.81% | 20.6% |
| Net Income | 55.93M | 51.4M | 79.36M | 38.33M | 35.73M | 45.48M | 27.18M | 15.57M | 932K | 8.69M | 80.75M | -33.21M |
| Depreciation & Amortization | 1.52M | 1.76M | 1.61M | 1.54M | 1.63M | 1.55M | 1.53M | 2.02M | 1.61M | 1.51M | 1.36M | 1.48M |
| Stock-Based Compensation | 13.61M | 0 | 0 | 14.12M | 13.48M | 13.36M | 13.32M | 13.16M | 9.3M | 9.85M | 8.31M | 11.33M |
| Deferred Taxes | 0 | 1.83M | -24.68M | 0 | 0 | 0 | 0 | 0 | 0 | -46.3M | 0 | 0 |
| Other Non-Cash Items | -4.69M | 13.01M | 11.24M | -1.76M | -1.34M | -1.89M | -1.36M | -1.62M | -2.25M | 44.73M | -102.16M | -1.97M |
| Working Capital Changes | 14.01M | 9.5M | -27.88M | 494K | -18.54M | -5.66M | 18.2M | -33.29M | 6.3M | -25.71M | -9.49M | -11.82M |
| Change in Receivables | 58K | 2.49M | -17.92M | -8.18M | 1.49M | -7.45M | 5.94M | -56.77M | -4.43M | -32.72M | -9.32M | 0 |
| Change in Inventory | -243K | -1.06M | -4.71M | 880K | -1.4M | -6.52M | -3.68M | 530K | -2.24M | -492K | -3.08M | -906K |
| Change in Payables | 1.02M | -183K | -4.02M | 4.12M | 906K | -591K | 91K | 784K | 727K | -222K | -360K | 374K |
| Cash from Investing | -63.58M | 11.16M | -4.29M | -10.53M | -54.77M | -83.78M | -34.33M | -19.35M | -25.98M | -10.16M | 105.19M | -15.96M |
| Capital Expenditures | -7.15M | -2.14M | -1.7M | -1.9M | -6.2M | -801K | -1.05M | -1.13M | -1.26M | -1.85M | -1.78M | -2.79M |
| CapEx % of Revenue | 6.14% | 2% | 1.74% | 1.98% | 7.04% | 0.88% | 1.25% | 1.61% | 2.78% | 4.38% | 20.82% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 435K | 0 | 0 | 0 | 0 | 0 | 100M | 0 |
| Cash from Financing | -10.46M | 15.67M | 3.71M | 1.8M | -12.47M | 2.43M | 3.37M | 10.64M | 10.58M | 2.62M | 13.39M | 185.27M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -10.46M | 15.69M | 3.71M | 1.8M | 0 | 0 | 0 | 0 | 0 | 2.62M | -122K | 185.27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -16.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -23K | -5K | 0 | -12.47M | 2.43M | 3.37M | 10.64M | 10.58M | 0 | 13.51M | 0 |
| Net Change in Cash | 5.01M | 103.7M | 38.77M | 45.06M | -36.09M | -29.1M | 28.18M | -13.22M | 678K | -14.91M | 97.37M | 135.13M |
| Free Cash Flow | 73.23M | 75.37M | 37.95M | 50.83M | 24.77M | 52.04M | 57.81M | -5.3M | 14.63M | -9.08M | -23.01M | -36.98M |
| FCF Margin % | 62.94% | 70.37% | 38.81% | 52.92% | 28.08% | 57.1% | 68.95% | -7.54% | 32.33% | -21.54% | -268.9% | - |
| FCF Growth % | 195.72% | 44.82% | -34.35% | 1059.14% | 69.3% | 673.21% | 351.28% | 85.67% | 146.38% | 67.04% | 31.82% | 37.93% |
| FCF per Share | 2.40 | 2.52 | 1.27 | 1.71 | 0.83 | 1.74 | 1.93 | -0.18 | 0.50 | -0.32 | -0.80 | -1.39 |
| FCF Conversion (FCF/Net Income) | 1.44x | 1.51x | 0.50x | 1.38x | 0.87x | 1.16x | 2.17x | -0.27x | 17.05x | -0.83x | -0.26x | 1.03x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 18K | 13.46M | 400K | 515K | 3.15M | 2M | 0 | 0 | 0 | 0 |